Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000339327

Medchemexpress LLC Remibrutinib | 1787294-07-8 | 99.8% | 100 MG
SDP

Catalog No. 5000339327
Encompass_Preferred

Remibrutinib is a potent and orally active Bruton tyrosine kinase (BTK) inhibitor with an IC50 value of 1 nM. It inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib has potential for Chronic Urticaria (CU) treatment. This product is for research use only and not sold to patients.

  • Potent and orally active Bruton tyrosine kinase (BTK) inhibitor
  • Inhibits BTK enzymatic activity with an IC50 value of 1 nM
  • Inhibits BTK activity in blood with an IC50 value of 0.023 μM
  • Potential for Chronic Urticaria (CU) treatment
  • Molecular weight: 507.53
  • Chemical formula: C27H27F2N5O3
  • Appearance: white to off-white solid

Catalog No. 50-003-39327 Supplier Medchemexpress LLC Supplier No. HY128757100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Remibrutinib is a potent and orally active Bruton tyrosine kinase (BTK) inhibitor with an IC50 value of 1 nM. It inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib has potential for Chronic Urticaria (CU) treatment. This product is for research use only and not sold to patients.

  • Potent and orally active Bruton tyrosine kinase (BTK) inhibitor
  • Inhibits BTK enzymatic activity with an IC50 value of 1 nM
  • Inhibits BTK activity in blood with an IC50 value of 0.023 μM
  • Potential for Chronic Urticaria (CU) treatment
  • Molecular weight: 507.53
  • Chemical formula: C27H27F2N5O3
  • Appearance: white to off-white solid

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.